Q3 2020 G1 Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the G1 Therapeutics 3Q 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions) As a reminder, today's program may be recorded. And now I'd like to hand the conference over to your first speaker for today, the head of Investor Relations, Mr. Jeff Macdonald. Please go ahead, sir. Thank you.
Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics Third Quarter 2020 Corporate Financial Update. Joining me today are Mark Velleca, Chief Executive Officer; Raj Malik, Chief Medical Officer and Senior Vice President, R&D; Soma Gupta, Chief Commercial Officer; and Jen Moses, Chief Financial Officer. I'm also pleased to welcome Jack Bailey, who as previously announced, will succeed Dr. Velleca as Chief Executive Officer, effective January 1, 2021.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
